TY - JOUR T1 - Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold JF - medRxiv DO - 10.1101/2020.04.27.20081893 SP - 2020.04.27.20081893 AU - M. Gabriela M. Gomes AU - Rodrigo M. Corder AU - Jessica G. King AU - Kate E. Langwig AU - Caetano Souto-Maior AU - Jorge Carneiro AU - Guilherme Gonçalves AU - Carlos Penha-Gonçalves AU - Marcelo U. Ferreira AU - Ricardo Aguas Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/12/2020.04.27.20081893.abstract N2 - As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads, the susceptible subpopulation is depleted causing the incidence of new cases to decline. Variation in individual susceptibility or exposure to infection exacerbates this effect. Individuals that are more susceptible or more exposed tend to be infected earlier, depleting the susceptible subpopulation of those who are at higher risk of infection. This selective depletion of susceptibles intensifies the deceleration in incidence. Eventually, susceptible numbers become low enough to prevent epidemic growth or, in other words, the herd immunity threshold (HIT) is reached. Although estimates vary, simple calculations suggest that herd immunity to SARS-CoV-2 requires 60-70% of the population to be immune. By fitting epidemiological models that allow for heterogeneity to SARS-CoV-2 outbreaks across the globe, we show that variation in susceptibility or exposure to infection reduces these estimates. Accurate measurements of heterogeneity are therefore of paramount importance in controlling the COVID-19 pandemic.One Sentence Summary Models that curtail individual variation in susceptibility or exposure to infection overestimate epidemic sizes and herd immunity thresholds.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript are publicly available. https://www.worldometers.info/coronavirus/#countries ER -